NCT04588935View on ClinicalTrials.gov

Prevention of Cardiovascular Diseases Caused by Complex Treatment of Patients With Primary Operated Breast Cancer

PHASE2CompletedINTERVENTIONAL

Enrollment

100

Participants

Timeline

Start Date

July 1, 2019

Primary Completion Date

February 7, 2023

Study Completion Date

February 7, 2023

Conditions

Women With Breast Cancer

Interventions

DRUG

Bisoprolol; Perindopril;

based on the results of the patient study, different drug therapy regimens for cardiovascular complications during chemotherapy will be proposed

Trial Locations (1)

220000

Scientific and Practice Center of Cardiology, Minsk

All Listed Sponsors

lead

"State Institution Republican Scientific and Practical Center Cardiology, Belarus"

OTHER

NCT04588935 - Prevention of Cardiovascular Diseases Caused by Complex Treatment of Patients With Primary Operated Breast Cancer | Biotech Hunter | Biotech Hunter